Vicero was pleased to present a poster at the inaugural AACR IO Meeting on February 23-26, 2025 in Los Angeles, CA. The abstract, “VCR-036 VINCOBODY: A novel, highly potent, pentavalent, toxicity-sparing PD-1/CTLA-4 VHH neutralizer with robust pre-clinical safety and efficacy,” can be viewed in Clinical Cancer Research, and the poster is available for viewing below.
© Copyright 2025